Crispr Therapeutics shares owned by Thrivent Financial for Lutherans
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Thrivent Financial for Lutherans
from 13F filings
Historical chart of Thrivent Financial for Lutherans investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Thrivent Financial for Lutherans consolidated in one spreadsheet with up to 7 years of data
Download as csv![Download consolidated filings csv](/static/img/csv.png)
![Download consolidated filings xlsx](/static/img/microsoft-excel.png)
Quarterly reported holdings in Crispr Therapeutics by Thrivent Financial for Lutherans
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $2.1M | 31k | 68.17 |
2023-09-30 | $1.5M | 34k | 45.40 |
2023-06-30 | $2.7M | 49k | 56.07 |
2023-03-31 | $2.2M | 49k | 45.20 |
2022-12-31 | $3.2M | 79k | 40.66 |
2022-09-30 | $1.6M | 25k | 65.45 |
2022-06-30 | $1.3M | 21k | 60.77 |
2022-03-31 | $733k | 12k | 62.75 |
2021-12-31 | $3.1M | 40k | 75.77 |
2021-09-30 | $209k | 1.9k | 111.88 |
2021-06-30 | $640k | 4.0k | 161.85 |
2021-03-31 | $315k | 2.6k | 121.95 |
2020-12-31 | $247k | 1.6k | 153.32 |
More positions owned by Thrivent Financial for Lutherans
View all positions for Thrivent Financial for Lutherans